Krystal Biotech buy Guggenheim
Start price
07.05.25
/
50%
€120.90
Target price
07.05.26
€166.60
Performance (%)
-0.62%
Price
10:34
€120.15
Summary
This prediction is currently active. Since the start of the prediction for Krystal Biotech the price has only changed by -0.62%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -9.905% | -9.905% |
| iShares Core DAX® | -1.351% | 0.610% |
| iShares Nasdaq 100 | -1.453% | 3.019% |
| iShares Nikkei 225® | -0.021% | 1.195% |
| iShares S&P 500 | -1.326% | 2.830% |
Comments by Guggenheim for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Guggenheim from $195.00 to $189.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Guggenheim for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€161.18
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
